The Valley Desk

NCT00294515 · Interventional trial

IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients

Overall registry status Completed

Phase 3

Conditions Cytomegalovirus Infections

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov